SCHEMBL3975720

SCHEMBL3975720

N#Cc1cc(C(=O)NNC(=O)c2cc(-c3ccccc3)co2)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CTDSP1 Q9GZU7 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
GCGR P47871 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
SLC22A12 Q96S37 1/20 0.38
KAT6A Q92794 1/20 0.38
S1PR3 Q99500 1/20 0.38
XDH P47989 1/20 0.38
GRM5 P41594 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978665 0.88 MCL1 (0.47)
SCHEMBL3974740 0.86 GUSB (0.48) MEN1KMT2A
SCHEMBL3973929 0.83 MCL1 (0.47) GCGRXDH
SCHEMBL3975924 0.80 GRM5 (0.41) MEN1KMT2AGCGRKDM4ELMNA
SCHEMBL3974756 0.79 GCGR (0.46) GCGRGRM5
SCHEMBL3984487 0.78 GCGR (0.44) CTDSP1GCGRPOLBMAPTGRM5
SCHEMBL3978186 0.76 GCGR (0.42) GCGRGRM5
SCHEMBL3976559 0.76 GCGR (0.41) GCGRGRM5
SCHEMBL3978278 0.76 GCGR (0.47) GCGRSLC22A12GRM5
SCHEMBL3977114 0.76 GRM5 (0.43) GCGRGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 MEN1 1481/4885KMT2A 3459/4885CTDSP1 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.